Propanc Biopharma, a Nasdaq-listed biotech firm, has secured up to $100 million to bolster its digital asset strategy.
Related Posts
Market update: Bitcoin rises after US-EU announce framework trade agreement
Bitcoin (BTC) traded above $119,430 Monday, up 1.24%, after a US-EU trade deal was announced. The US-EU deal…
One in Six BTC on Centralized Exchanges Despite FTX Collapse
Nearly 3 million Bitcoin (BTC), worth approximately $200 billion and representing 15% of the circulating supply, currently sits…
Coinbase to delist six altcoins, including OOKI and VGX
Coinbase, the leading US digital asset trading platform, will suspend trading of six cryptocurrencies as part of its…